[6-K] New Found Gold Corp Current Report (Foreign Issuer)
Form 4 filing for Kellanova (K): On 07/21/2025 the W.K. Kellogg Foundation Trust, a 10 % beneficial owner, sold 114,583 common shares at $79.92. Post-sale holding is 45,670,369 shares, so the divestiture reduces its stake by roughly 0.25 %. The sales were executed under a pre-arranged Rule 10b5-1 plan adopted 05/07/2024. No derivative securities were involved and no other insiders transacted.
The filing provides no earnings data or strategic commentary; it simply discloses a routine, plan-based share sale by the Trust鈥檚 corporate trustees.
Dichiarazione Form 4 per Kellanova (K): Il 21/07/2025 il W.K. Kellogg Foundation Trust, detentore del 10% delle azioni, ha venduto 114.583 azioni ordinarie a 79,92 $. Dopo la vendita, la partecipazione 猫 di 45.670.369 azioni, quindi la cessione riduce la quota di circa lo 0,25%. Le vendite sono state effettuate nell鈥檃mbito di un piano predefinito ai sensi della Regola 10b5-1 adottato il 07/05/2024. Non sono stati coinvolti strumenti derivati e nessun altro insider ha effettuato transazioni.
La dichiarazione non fornisce dati sugli utili n茅 commenti strategici; si limita a comunicare una vendita di azioni di routine, basata su un piano, effettuata dai fiduciari aziendali del Trust.
Presentaci贸n del Formulario 4 para Kellanova (K): El 21/07/2025, el W.K. Kellogg Foundation Trust, propietario del 10%, vendi贸 114,583 acciones ordinarias a 79,92 $. Tras la venta, la participaci贸n es de 45,670,369 acciones, por lo que la desinversi贸n reduce su participaci贸n en aproximadamente un 0,25%. Las ventas se ejecutaron bajo un plan preestablecido conforme a la Regla 10b5-1 adoptado el 07/05/2024. No se involucraron valores derivados ni otros insiders realizaron transacciones.
La presentaci贸n no incluye datos de ganancias ni comentarios estrat茅gicos; simplemente revela una venta rutinaria de acciones basada en un plan por parte de los fideicomisarios corporativos del Trust.
Kellanova (K)鞚� Form 4 鞝滌稖: 2025雲� 7鞗� 21鞚�, 10% 歆�攵勳潉 氤挫湢頃� W.K. Kellogg Foundation Trust臧� 114,583欤� 氤错喌欤茧ゼ 欤茧嫻 79.92雼煬鞐� 毵る弰頄堨姷雼堧嫟. 毵る弰 頉� 氤挫湢 欤检嫕鞚� 45,670,369欤�搿�, 鞚措矆 毵り皝鞙茧 歆�攵勳澊 鞎� 0.25% 臧愳唽頄堨姷雼堧嫟. 毵る弰電� 2024雲� 5鞗� 7鞚� 毂勴儩霅� 靷爠 鞀轨澑霅� Rule 10b5-1 瓿勴殟鞐� 霐半澕 鞁ろ枆霅橃棃鞀惦媹雼�. 韺岇儩靸來拡 歃濌秾鞚� 韽暔霅橃 鞎婌晿鞙茧┌ 雼るジ 雮措秬鞛� 瓯半灅霃� 鞐嗢棃鞀惦媹雼�.
鞝滌稖 靹滊鞐愲姅 靾橃澋 雿办澊韯半倶 鞝勲灥鞝� 鞏戈笁鞚� 鞐嗢溂氅�, 雼 韸鸽煬鞀ろ姼鞚� 旮办梾 鞁犿儊 甏�毽瀽霌れ澊 瓿勴殟鞐� 霐半澕 鞚检儊鞝侅溂搿� 欤检嫕鞚� 毵る弰頄堨潓鞚� 瓿店皽頃╇媹雼�.
D茅p么t du formulaire 4 pour Kellanova (K) : Le 21/07/2025, le W.K. Kellogg Foundation Trust, d茅tenteur de 10 %, a vendu 114 583 actions ordinaires 脿 79,92 $. Apr猫s la vente, la participation s鈥櫭﹍猫ve 脿 45 670 369 actions, ce qui r茅duit sa part d鈥檈nviron 0,25 %. Les ventes ont 茅t茅 r茅alis茅es dans le cadre d鈥檜n plan pr茅茅tabli conforme 脿 la r猫gle 10b5-1 adopt茅 le 07/05/2024. Aucun titre d茅riv茅 n鈥櫭﹖ait impliqu茅 et aucun autre initi茅 n鈥檃 effectu茅 de transaction.
Le d茅p么t ne fournit ni donn茅es sur les b茅n茅fices ni commentaires strat茅giques ; il se contente de r茅v茅ler une vente d鈥檃ctions de routine bas茅e sur un plan par les administrateurs corporatifs du Trust.
Formular 4 Meldung f眉r Kellanova (K): Am 21.07.2025 verkaufte der W.K. Kellogg Foundation Trust, ein 10%iger Beg眉nstigter, 114.583 Stammaktien zu je 79,92 $. Nach dem Verkauf h盲lt er 45.670.369 Aktien, wodurch sich sein Anteil um etwa 0,25 % verringert. Die Verk盲ufe erfolgten im Rahmen eines vorab vereinbarten Rule 10b5-1 Plans, der am 07.05.2024 angenommen wurde. Es waren keine derivativen Wertpapiere beteiligt und keine weiteren Insider haben Transaktionen get盲tigt.
Die Meldung enth盲lt keine Gewinnzahlen oder strategische Kommentare; sie offenbart lediglich einen routinem盲脽igen, planbasierten Aktienverkauf durch die Corporate Trustees des Trusts.
- Sale executed under a Rule 10b5-1 plan, mitigating information-asymmetry concerns and demonstrating compliance with insider-trading safeguards.
- Insider selling by a 10 % owner can be perceived as a modestly negative sentiment signal even though the percentage sold is small.
Insights
TL;DR: Small 10%-owner sale under 10b5-1; negligible dilution, slightly negative sentiment.
The Trust sold 114.6k shares鈥攐nly 0.25 % of its 45.7 m-share position鈥攊ndicating portfolio rebalancing rather than an adverse view on fundamentals. Use of a Rule 10b5-1 plan reduces information-risk, limiting market impact. Given Kellanova鈥檚 average daily volume (~2 m shares), the trade represents about 6 % of one day鈥檚 liquidity and should be easily absorbed. I view the disclosure as low impact and slightly negative from a sentiment perspective, but not thesis-changing.
TL;DR: Governance-compliant, pre-planned insider sale; minimal governance concern.
The Trust remains a >10 % holder after the transaction, preserving significant alignment with public shareholders. Execution through a 10b5-1 plan, in place since May 2024, signals adherence to best-practice insider trading controls. No new powers, pledges or derivative positions were disclosed. Consequently, I deem the event not materially impactful for governance risk assessments.
Dichiarazione Form 4 per Kellanova (K): Il 21/07/2025 il W.K. Kellogg Foundation Trust, detentore del 10% delle azioni, ha venduto 114.583 azioni ordinarie a 79,92 $. Dopo la vendita, la partecipazione 猫 di 45.670.369 azioni, quindi la cessione riduce la quota di circa lo 0,25%. Le vendite sono state effettuate nell鈥檃mbito di un piano predefinito ai sensi della Regola 10b5-1 adottato il 07/05/2024. Non sono stati coinvolti strumenti derivati e nessun altro insider ha effettuato transazioni.
La dichiarazione non fornisce dati sugli utili n茅 commenti strategici; si limita a comunicare una vendita di azioni di routine, basata su un piano, effettuata dai fiduciari aziendali del Trust.
Presentaci贸n del Formulario 4 para Kellanova (K): El 21/07/2025, el W.K. Kellogg Foundation Trust, propietario del 10%, vendi贸 114,583 acciones ordinarias a 79,92 $. Tras la venta, la participaci贸n es de 45,670,369 acciones, por lo que la desinversi贸n reduce su participaci贸n en aproximadamente un 0,25%. Las ventas se ejecutaron bajo un plan preestablecido conforme a la Regla 10b5-1 adoptado el 07/05/2024. No se involucraron valores derivados ni otros insiders realizaron transacciones.
La presentaci贸n no incluye datos de ganancias ni comentarios estrat茅gicos; simplemente revela una venta rutinaria de acciones basada en un plan por parte de los fideicomisarios corporativos del Trust.
Kellanova (K)鞚� Form 4 鞝滌稖: 2025雲� 7鞗� 21鞚�, 10% 歆�攵勳潉 氤挫湢頃� W.K. Kellogg Foundation Trust臧� 114,583欤� 氤错喌欤茧ゼ 欤茧嫻 79.92雼煬鞐� 毵る弰頄堨姷雼堧嫟. 毵る弰 頉� 氤挫湢 欤检嫕鞚� 45,670,369欤�搿�, 鞚措矆 毵り皝鞙茧 歆�攵勳澊 鞎� 0.25% 臧愳唽頄堨姷雼堧嫟. 毵る弰電� 2024雲� 5鞗� 7鞚� 毂勴儩霅� 靷爠 鞀轨澑霅� Rule 10b5-1 瓿勴殟鞐� 霐半澕 鞁ろ枆霅橃棃鞀惦媹雼�. 韺岇儩靸來拡 歃濌秾鞚� 韽暔霅橃 鞎婌晿鞙茧┌ 雼るジ 雮措秬鞛� 瓯半灅霃� 鞐嗢棃鞀惦媹雼�.
鞝滌稖 靹滊鞐愲姅 靾橃澋 雿办澊韯半倶 鞝勲灥鞝� 鞏戈笁鞚� 鞐嗢溂氅�, 雼 韸鸽煬鞀ろ姼鞚� 旮办梾 鞁犿儊 甏�毽瀽霌れ澊 瓿勴殟鞐� 霐半澕 鞚检儊鞝侅溂搿� 欤检嫕鞚� 毵る弰頄堨潓鞚� 瓿店皽頃╇媹雼�.
D茅p么t du formulaire 4 pour Kellanova (K) : Le 21/07/2025, le W.K. Kellogg Foundation Trust, d茅tenteur de 10 %, a vendu 114 583 actions ordinaires 脿 79,92 $. Apr猫s la vente, la participation s鈥櫭﹍猫ve 脿 45 670 369 actions, ce qui r茅duit sa part d鈥檈nviron 0,25 %. Les ventes ont 茅t茅 r茅alis茅es dans le cadre d鈥檜n plan pr茅茅tabli conforme 脿 la r猫gle 10b5-1 adopt茅 le 07/05/2024. Aucun titre d茅riv茅 n鈥櫭﹖ait impliqu茅 et aucun autre initi茅 n鈥檃 effectu茅 de transaction.
Le d茅p么t ne fournit ni donn茅es sur les b茅n茅fices ni commentaires strat茅giques ; il se contente de r茅v茅ler une vente d鈥檃ctions de routine bas茅e sur un plan par les administrateurs corporatifs du Trust.
Formular 4 Meldung f眉r Kellanova (K): Am 21.07.2025 verkaufte der W.K. Kellogg Foundation Trust, ein 10%iger Beg眉nstigter, 114.583 Stammaktien zu je 79,92 $. Nach dem Verkauf h盲lt er 45.670.369 Aktien, wodurch sich sein Anteil um etwa 0,25 % verringert. Die Verk盲ufe erfolgten im Rahmen eines vorab vereinbarten Rule 10b5-1 Plans, der am 07.05.2024 angenommen wurde. Es waren keine derivativen Wertpapiere beteiligt und keine weiteren Insider haben Transaktionen get盲tigt.
Die Meldung enth盲lt keine Gewinnzahlen oder strategische Kommentare; sie offenbart lediglich einen routinem盲脽igen, planbasierten Aktienverkauf durch die Corporate Trustees des Trusts.
FAQ
Who sold Kellanova (K) shares on 07/21/2025?
How many Kellanova shares were sold in the Form 4 filing?
At what price were the Kellanova shares sold?
How many Kellanova shares does the W.K. Kellogg Foundation Trust own after the sale?
Was the Kellanova insider sale pre-planned?
Does the filing mention derivative securities or additional transactions?
